Catalyst components for the polymerization of olefins
申请人:Basell Poliolefine Italia S.r.l.
公开号:EP2583985A1
公开(公告)日:2013-04-24
Catalyst component for the polymerization of olefins comprising Mg, Ti and an electron donor compound of the following formula (I)
In which
R to R4 groups, equal to or different from each other, are hydrogen, halogen or C1-C15 hydrocarbon groups, optionally containing an heteroatom selected from halogen, P, S, N and Si, which may be linked to form a saturated or unsaturated mono or polycycle and R5 groups, are selected from C1-C15 hydrocarbon groups optionally containing an heteroatom selected from halogen, P, S, N and Si.
用于烯烃聚合的催化剂组分,由 Mg、Ti 和下式 (I) 的电子供体化合物组成
其中
R 至 R4 基团(彼此相等或不同)为氢、卤素或 C1-C15 烃基,可选择含有选自卤素、P、S、N 和 Si 的杂原子,它们可连接形成饱和或不饱和单环或多环及 R5 基团,可选择含有选自卤素、P、S、N 和 Si 的杂原子的 C1-C15 烃基。
CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS
申请人:Basell Poliolefine Italia S.r.l.
公开号:EP2768873B1
公开(公告)日:2017-11-22
TOPICAL COMPOSITIONS
申请人:GREEN Monique Renata
公开号:US20130243707A1
公开(公告)日:2013-09-19
Topical compositions are disclosed that are useful for delivering a therapeutic level of an NSAID to a target within a subject having a local inflammatory disorder. A composition of the present invention comprises a Drug and a solvent system, wherein the solvent system comprises at least two solvent alcohols and wherein the solvent system is present in an amount sufficient to solubilize the Drug, the solvent system is a low alkanol system, and the composition is a single phase composition. Exemplary solvent systems are those for which one of the at least two solvent alcohols is polyethylene glycol, glycerin, butylene glycol, diproylene glycol, propylene glycol, ethanol, isopropanol, or a derivative thereof. Optionally the local inflammatory disorder is pseudofolliculitis barbae, dermatitis, psoriasis, wounds, or sunburn.
NEW PYRIDINE CARBOXAMIDES
申请人:BASF SE
公开号:US20200354321A1
公开(公告)日:2020-11-12
The present invention relates to the use of compounds of formula I, wherein the variables are defined as given in the description and claims. The invention further relates to the compounds I and composition for compounds of formula I.